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A B S T R A C T
Background: Preterm birth is associated with dysconnectivity of structural brain networks, impaired cognition
and psychiatric disease. Systemic inflammation contributes to cerebral dysconnectivity, but the immune med-
iators driving this association are poorly understood. We analysed information from placenta, umbilical cord and
neonatal blood, and brain MRI to determine which immune mediators link perinatal systemic inflammation with
dysconnectivity of structural brain networks.
Methods: Participants were 102 preterm infants (mean gestational age 29+1 weeks, range 23+3-32+0). Placental
histopathology identified reaction patterns indicative of histologic chorioamnionitis (HCA), and a customized
immunoassay of 24 inflammation-associated proteins selected to reflect the neonatal innate and adaptive im-
mune response was performed from umbilical cord (n = 55) and postnatal day 5 blood samples (n = 71). Brain
MRI scans were acquired at term-equivalent age (41+0 weeks [range 38+0-44+4 weeks]) and alterations in
white matter connectivity were inferred from mean diffusivity and neurite density index across the white matter
skeleton.
Results: HCA was associated with elevated concentrations of C5a, C9, CRP, IL-1β, IL-6, IL-8 and MCP-1 in cord
blood, and IL-8 concentration predicted HCA with an area under the receiver operator curve of 0.917 (95% CI
0.841 – 0.993, p < 0.001). Fourteen analytes explained 66% of the variance in the postnatal profile (BDNF, C3,
C5a, C9, CRP, IL-1β, IL-6, IL-8, IL-18, MCP-1, MIP-1β, MMP-9, RANTES and TNF-α). Of these, IL-8 was asso-
ciated with altered neurite density index across the white matter skeleton after adjustment for gestational age at
birth and at scan (β = 0.221, p = 0.037).
Conclusions: These findings suggest that IL-8 dysregulation has a role in linking perinatal systemic inflammation
and atypical white matter development in preterm infants.
1. Introduction
Preterm birth affects around 15 million births annually
(Chawanpaiboon et al., 2019), and is an important cause of cerebral
palsy, cognitive impairment, autism spectrum disorder and psychiatric
disease later in life (Twilhaar et al., 2018). Magnetic resonance imaging
(MRI) studies reveal a cerebral phenotype of preterm birth that is as-
sociated with later function, and includes diffuse white matter disease,
dysconnectivity of developing networks, and structural alterations in
cortical and deep grey matter (Ball et al., 2017; Batalle et al., 2017;
Boardman et al., 2010; Galdi et al., 2020; Kapellou et al., 2006). These
image features are manifest by term-equivalent age, which suggests that
interventions to prevent injury and restore typical development may
need to be applied during the perinatal period.
Immune dysregulation at a critical point in neurodevelopment is
strongly implicated in the pathogenesis of the encephalopathy of
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prematurity, which can be conceptualized as white matter injury and
subsequent dysmaturation of diverse cellular processes resulting in
atypical development of white and grey matter structures (Hagberg
et al., 2015; Volpe, 2019). Preterm infants have a distinct inflammatory
profile in blood and cerebrospinal fluid (CSF) that includes higher levels
of pro-inflammatory cytokines and lower levels of neuroprotective
growth factors compared to infants born at term (Boardman et al.,
2018; Skogstrand et al., 2008), and there is evidence that both systemic
inflammation and neuroinflammation are associated with overt forms
of preterm brain injury. For example, elevated IL-1β, IL-6, IL-8 and IL-
10 in umbilical cord and early postnatal blood is associated with in-
traventricular hemorrhage and white matter lesions soon after birth
(Duggan et al., 2001; Leviton et al., 2018; Yoon et al., 1996), and
persistently elevated pro-inflammatory proteins during the first 2 weeks
after preterm birth are associated with increased risk of cerebral palsy
(Carlo et al., 2011; Kuban et al., 2014) and impaired neurocognitive
development in infancy and childhood (Hansen-Pupp et al., 2008;
Kuban et al., 2017; Leviton et al., 2016; O'Shea et al., 2012, 2013; Yanni
et al., 2017). Furthermore, specific co-morbidities of preterm birth
characterized by systemic inflammation, including intrauterine in-
flammation (histologic chorioamnionitis, HCA) and necrotizing en-
terocolitis, are associated with abnormal white matter on magnetic
resonance imaging (Anblagan et al., 2016; Ball et al., 2017; Barnett
et al., 2018; Shah et al., 2008). However, previous study designs leave
uncertainty about which immune mediators are associated with white
matter dysmaturation and network dysconnectivity.
Diffusion tensor MRI (DTI) and neurite orientation dispersion and
density imaging (NODDI) support inference about the microstructural
properties of developing white matter (Pietsch et al., 2019; Tariq et al.,
2016; Zhang et al., 2012). Specifically, normal brain maturation is
characterized by a reduction in white matter mean diffusivity (MD) and
an increase in neurite density index (NDI); but MD is increased and NDI
decreased in preterm infants at term equivalent age, compared with
healthy controls infants born at term (Pecheva et al., 2018). These
changes reflect an increase in water content and a decrease in white
matter organization in preterm infants. Peak width of skeletonised
mean diffusivity (PSMD) is a method for histogram based calculation of
MD distribution across the entire white matter skeleton, which provides
a measure of generalized white matter microstructure and dysconnec-
tivity that is related to cognition (Baykara et al., 2016; Deary et al.,
2019; Wei et al., 2019). In previous work we extended the histogram
model to include peak width of skeletonised neurite density index
(PSNDI) and found that PSMD and PSNDI are both altered in preterm
infants at term equivalent age, indicating that these are useful bio-
markers of generalized white matter connectivity in the developing
brain (Blesa et al., 2020).
Identification of immune mediators of generalized dysconnectivity
during the perinatal period is important for elucidating new targets for
neuroprotection therapies. In this study, we utilized an immunoassay of
24 analytes customized to reflect perinatal innate and adaptive immune
responses, and analyzed profiles from umbilical cord and postnatal
blood samples with placental histopathology and brain MRI to test the
hypothesis that specific immune mediators link systemic inflammation
with atypical white matter development in preterm infants. We found
that elevated IL-8 is a characteristic feature of intrauterine and post-
natal systemic inflammation, and it is associated with white matter
dysconnectivity in preterm infants.
2. Methods and materials
2.1. Participants
Participants were 102 preterm infants born ≤32+0 weeks’ gesta-
tion, delivered at the Royal Infirmary of Edinburgh, UK and recruited to
a longitudinal study of the effect of preterm birth on brain development
and long term outcome (Boardman et al., 2020). Exclusion criteria
included infants with major congenital abnormality, post-hemorrhagic
ventricular dilatation, cystic periventricular leukomalacia, or contra-
indications to MRI. Ethical approval was obtained from the UK National
Research Ethics Service and parents provided written informed consent
(South East Scotland Research Ethics Committee 16/SS/0154). Subsets
were used to investigate relationships between inflammatory mediators
in umbilical cord blood and HCA (n = 55), and between inflammation
in the postnatal period and MRI markers of white matter connectivity
(n = 71).
2.2. Blood sample collection
2.2.1. Collection procedure
Dried blood spot samples (DBSS) were taken from the umbilical
cord following delivery and from blood drawn on day 5 of life using a
FTATM DMPK-A Card (WhatmanTM GE Healthcare). Bloodspot cards
were dried at room temperature and then stored at −20 °C until ana-
lysis at the Statens Serum Institut (Center for Neonatal Screening,
Copenhagen, Denmark). A customized multiple sandwich immunoassay
based on meso-scale technology was used to measure blood spot levels
of Interleukin (IL)1-β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17,
IL-18, Monocyte chemotactic protein-1 (MCP-1), Macrophage in-
flammatory protein-1α (MIP-1α), Macrophage inflammatory protein-
1β (MIP-1β), Tumor necrosis factor-α (TNF-α), Tumor necrosis factor-β
(TNF-β), Brain-derived neurotrophic factor (BDNF), Granulocyte-mac-
rophage colony-stimulating factor (GM-CSF), Interferon-γ (IFN-γ), C-
reactive protein (CRP), matrix-metalloproteinase 9 (MMP-9), Regulated
upon activation, normal T cell expressed and secreted (RANTES) and
Complement components C3, C5a and C9.
2.2.2. Dried blood spot sample analysis
Two 3.2 mm disks from the DBSS were punched into each well of
Nunc 96-well polystyrene microwell plates (#277143, Thermo Fisher
Scientific). 130 µl extraction buffer (PBS containing 1% BSA (Sigma
Aldrich #A4503), 0.5% Tween-20 (#8.22184.0500, Merck Millipore),
and complete protease inhibitor cocktail (#11836145001, Roche
Diagnostics)) was added to each well, and the samples were incubated
for 1 h at room temperature on a microwell shaker set at (900 rpm). The
extracts were analyzed using U-plex plates (Meso-Scale Diagnostics
(MSD), Maryland, US) coated with antibodies specific for IL-1β, IL-2, IL-
4, IL-5, IL-6, IL-8, IL-12, IL-17, TNF-α, MIP-1β on one plate (#K15067
customized) and BDNF, GM-CSF, IL-10, IL-18, IFN-γ, TNF-β, MCP-1,
MIP-1α on another (#K151AC customized) (both MSD). Supplier’s in-
structions were followed, and extracts were analysed undiluted. A third
multiplex analysis was developed in-house applying extracts diluted
1:10 in diluent 7 (#R54BB, MSD) using antibodies specific for C3
(HYB030-07 and HYB030-06, SSI Antibodies, Copenhagen, Denmark),
C5a (10604-MM04 and 10604-MM06, Sino Biological, Eschborn,
Germany), C9 (R-plex kit #F21XZ, MSD), MMP-9 (BAF911 and
MAB911), RANTES (MAB278 and AF278NA) and CRP (BAM17072 and
MAB1701) (all R&D Systems, Minneapolis, US) for coating the U-plex
plate and for detection, respectively. Coating antibodies (used at 1 μg/
mL, except CRP used at 10 ng/mL) were biotinylated (using EZ-Link
Sulfo-NHS-LC-Biotin #21327, Thermo Fisher Scientific) in-house (if not
already biotinylated at purchase) and detection antibodies were
SULFO-tagged (R91AO, MSD), both at a challenge ratio of 20:1. The
following calibrators were used: C3: #PSP-109 (Nordic Biosite,
Copenhagen, DK), C5a: #10604-HNAE (Sino Biological), C9: #F21XZ
(from R-plex kit, MSD), MMP-9: #911-MP, RANTES: #278-RN and
CRP: #1707-CR/CF (all from R&D Systems). Calibrators were diluted in
diluent 7, detection antibodies (used at 1 μg/mL, except CRP used at
100 ng/mL) were diluted in diluent 3 (#R50AP, MSD). Controls were
made in-house from part of the calibrator solution in one batch, ali-
quoted in portions for each plate and stored at −20 °C until use. The
samples were prepared on the plates as recommended from the man-
ufacturer and were immediately read on the QuickPlex SQ 120 (MSD).
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Analyte concentrations were calculated from the calibrator curves on
each plate using 4PL logistic regression using the MSD Workbench
software.
2.2.3. Analytical characterization
Intra-assay variations were calculated from 16 measurements of a
pool of the same control sample on the same plate. Inter-assay varia-
tions were calculated from controls analyzed in duplicate on each plate
during the sample analysis, 4 plates in total. Limit of detections were
calculated as 2.5 standard deviations from duplicate measurements of
the zero calibrator. The higher detection limit was defined as the
highest calibrator concentration. The median intra-assay variation was
8.2% and median inter-assay variation was 11.1%. The inter-assay
variation was largely influenced by CRP, RANTES and MMP-9.
Detection limits and assay variations are shown in Supplementary Table
S1.
2.3. Placental histopathology
Placental examination was performed by an experienced perinatal
pathologist (M.J.E.) and placental reaction patterns were reported ac-
cording to the site and degree of inflammation, using a structured
system (Redline et al., 2003). HCA was defined as the presence of an
inflammatory response in the placental membranes of any grade or
stage.
2.4. Magnetic resonance imaging
2.4.1. MRI procedure
Structural and diffusion MRI brain scans were performed at mean
gestational age (GA) 41+0 weeks (range 38+0-44+4 weeks). Infants
were scanned in natural sleep with monitoring of pulse oximetry,
electrocardiography and temperature. For ear protection, flexible ear-
plugs and neonatal earmuffs (MiniMuffs, Natus Medical Inc., CA) were
used. All scans were supervised by a neonatal doctor and research
midwife. MRI scans were performed on a Siemens Magnetom Verio 3T
scanner (Siemens Healthcare, Erlangen, Germany) using a 16-channel
phased array head coil. Infants were scanned to acquire: 3D T1-
weighted (T1w) MPRAGE volume (TR = 1970 ms, TE = 4.69 ms, in-
version time = 1100 ms, flip angle = 9° acquisition plane = sagittal,
voxel size = 1 × 1 × 1 mm3, FOV = 160 mm, acquisition
time = 3:09), axial T2-weighted BLADE (TR = 4100 ms, TE = 207 ms,
voxel size = 0.7 × 0.7 × 3.0 mm3, FOV = 220 mm, acquisition
time = 2:29), T2-weighted SPACE (TR = 3200 ms, TE = 409 ms,
acquisition plane = sagittal, voxel size 1 × 1 × 1 mm3,
FOV = 128 mm, acquisition time = 2:13), SWI (TR = 28 ms,
TE = 20 ms, voxel size = 0.8 × 0.8 × 3.0 mm3, acquisition
time = 2:23) and axial T2-weighted FLAIR BLADE (TR = 10000,
TE = 130, voxel size = 0.9 × 0.9 × 3.0 mm3, acquisition
time = 3:22). Diffusion MRI data were acquired in 2 parts with inter-
spersed T2-weighted (b = 0 s/mm2) volumes: part 1 consisting of
8b = 0 s/mm2 and 64 diffusion-weighted b = 750 s/mm2, and part 2
consisting of 8b = 0 s/mm2, 3b = 200 s/mm2, 6b = 500 s/mm2 and
64b = 2500 s/mm2 single-shot spin-echo echo planar imaging (EPI)
volumes acquired with 2 mm isotropic voxels (TR = 3500 ms,
TE = 78 ms, FOV = 256 mm, acquired matrix 128 × 128, acquisition
time 4:29 + 5:01) (Boardman et al., 2020).
Structural images were reported by a pediatric radiologist with
experience in neonatal MRI (A.J.Q.) using an established system
(Leuchter et al., 2014). Images with evidence of post-hemorrhagic
ventricular dilatation, cystic periventricular leukomalacia or central
nervous system malformation were excluded.
2.4.2. MRI analysis
Diffusion MRI volumes were denoised using a Marchenko-Pastur-
PCA based algorithm (Tournier et al., 2019; Veraart et al., 2016). Eddy
current, head movement and EPI geometric distortions were corrected
using outlier replacement and slice-to-volume registration (Andersson
et al., 2003, 2017, 2016; Andersson and Sotiropoulos, 2016; Jenkinson
et al., 2012) and bias field inhomogeneity correction was applied
(Tustison et al., 2010). A template was constructed using data from 50
term born infants using DTI-TK and all the subjects were aligned (Blesa
et al., 2020; Zhang et al., 2006). The water diffusion tensor derived
maps of each subject were calculated after registration. The NODDI
maps were calculated in the subject’s native space with the NODDI-
Bingham model using cuDIMOT (Hernandez-Fernandez et al., 2019;
Tariq et al., 2016) and then the intracellular volume fraction [NDI] was
propagated to the template space using the previously calculated
transformations. The main skeleton of the fractional anisotropy (FA)
template was created by thresholding at 0.15, and individual FA maps
were projected onto this skeleton. Using this projection, the remaining
maps were also projected to the white matter skeleton. A custom mask
was created by editing the skeleton mask to remove CSF and grey
matter contaminated areas, and by removing tracts passing through the
cerebellum, the brainstem and subcortical grey matter areas. The re-
sulting skeletonized maps were then multiplied by the custom mask.
PSMD and PSNDI were calculated as the difference between the 95th
and 5th percentiles on histogram analysis (Blesa et al., 2020). Fig. 1
summarizes the pipeline for calculation of histogram based metrics.
2.5. Statistical analysis
Participant characteristics were compared using Student’s t-test or
Mann-Whitney U to compare distributions, and Chi-square tests were
used to compare proportions. To investigate group differences in im-
mune mediator profiles between those with and without HCA we used
the Mann-Whitney U test and Bonferroni correction for multiple tests.
Associations that remained significant after Bonferroni correction were
analysed in logistic regression models where HCA was the dependent
variable, analyte concentration was the independent variable, and GA
at birth was entered as a covariate. The predictive power of those
analytes that were associated with HCA after adjustment for GA at birth
was determined using receiver operator characteristic (ROC) analysis.
To investigate relationships between systemic inflammation and
white matter microstructure, principal component analysis (PCA) was
used to identify blood analytes contributing to variance in the postnatal
inflammatory profile. Analytes that contributed to PCs with eigenva-
lues> 1 were entered as independent variables in multivariable linear
regression models with PSMD and PSNDI as dependent variables, and
GA at birth and scan as covariates.
For all analyses, analytes with values less than the lower limit of
detection (< LOD) were assigned the lowest detectable level prior to
statistical analysis, and analytes with concentrations< LOD in ≥75%
of participants were excluded. Statistical analyses were performed
using SPSS version 24.0 (IBM Corp., Armonk, NY), with the exception




One hundred and two preterm infants (born before 32 weeks of
gestation) took part, and their clinical characteristics are shown in
Table 1. Fifty-five infants had umbilical cord blood obtained im-
mediately following delivery, and seventy-one infants had blood taken
on postnatal day 5 and had MRI performed at term-equivalent age.
3.2. Umbilical cord blood inflammatory profile associated with histologic
chorioamnionitis
Of 55 infants with umbilical cord blood sampling and placental
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histopathology, 24 (44%) were exposed to HCA during fetal life. Infants
with HCA exposure had lower GA at birth than infants without HCA:
mean GA 28+0 weeks versus 29+5 weeks (p = 0.002). There were no
statistically significant group differences in birthweight, infant sex, or
exposures to antenatal corticosteroids or magnesium sulphate for fetal
neuroprotection.
Ten of the 24 analytes had concentrations< LOD in ≥ 75% of both
groups and were therefore excluded from subsequent analyses. Table 2
shows umbilical cord blood analyte concentrations for infants exposed
to HCA and infants without HCA. Those exposed to HCA had higher
cord blood levels of C5a, C9, CRP, IL-1β, IL-6, IL-8 and MCP-1
(p < 0.003, Bonferroni corrected). Of these 7 analytes, 5 were
associated with HCA after adjustment for GA at birth in regression
models: C5a, IL-1β, IL-6, IL-8 and MCP-1 (β between 0.88 and 28.78,
p < 0.05). IL-8 concentration was the best predictor of HCA with an
area under the curve (AUC) of 0.917 (SE 0.039), 95% CI 0.841 – 0.993,
p < 0.001 (Fig. 2, Supplementary Table S2).
3.3. Postnatal inflammation and white matter microstructure
We investigated whether specific components of the perinatal im-
mune profile are associated with white matter microstructure (PSNDI
and PSMD), by studying a subset of infants who had their inflammatory
profile sampled on postnatal day 5 and brain MRI at term-equivalent
Fig. 1. Imaging pipeline for the construction of PSNDI. (A) shows the custom white matter skeleton, (B) shows the calculation of PSNDI from a histogram analysis of
neurite density index, and (C) shows a scatterplot of PSNDI versus gestational age at MRI scan.
Table 1
Clinical characteristics of participants.
Sample subset HCA prediction n = 55 MRI brain n = 71
Mean GA at birth, weeks (range) 29+0 (23+3-32+0) 29+4 (23+6-32+0)
Proportion of male infants (%) 60 58
Antenatal steroids, any (%) 98 96
Antenatal magnesium sulphate, any (%) 95 93
Mean birthweight, g (range) 1202 (454–2110) 1284 (600–2060)
Histologic chorioamnionitis, HCA (%) 44 30
Sepsis (%) – 18
Necrotizing enterocolitis, NEC (%) – 6
Bronchopulmonary dysplasia, BPD (%) – 25
Retinopathy of prematurity, ROP (%) – 6
Mean GA at scan, weeks (range) – 41+0 (38+0-44+4)
Sepsis: Positive blood culture with a pathogenic organism, or blood culture positive for coagulase negative staphylococcus / ne-
gative and treatment course for ≥5 days. Necrotizing enterocolitis: medical treatment for ≥7 days or surgical treatment.
Bronchopulmonary dysplasia: the need for supplemental oxygen therapy or respiratory support at 36+0 weeks gestational age.
Retinopathy of prematurity: requiring treatment with laser therapy.
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age.
The mean peak width of skeletonized neurite density index (PSNDI)
for the group was 0.238 mm2sec-1 x10-3 (SD 0.016), and mean PSMD
was 0.601 mm2sec-1 x10-3 (SD 0.062).
Using principal component analysis, we found that five PCs (ei-
genvalues > 1) explained 66% of the variance in the postnatal in-
flammatory profile, with most variance explained by the first two PCs
(23% and 15% respectively), Supplementary Table S3. Fourteen ana-
lytes contributed to the 5 PCs: BDNF, C3, C5a, C9, CRP, IL-1β, IL-6, IL-
8, IL-18, MCP-1, MIP-1β, MMP-9, RANTES and TNF-α (Supplementary
Fig. S4).
Of these 14 analytes, IL-8 was the only one to be associated with
PSNDI (β = 0.221, p = 0.037), in a multivariable model that explained
48% of the variance in PSNDI at term-equivalent age (F (16,54) = 5.09,
R2 adjusted = 0.48, p < 0.001) (Fig. 3, Supplementary Table S5).
None of the remaining 13 analytes were associated with PSNDI and
there were no significant associations between any analyte and PSMD.
4. Discussion
By combining data from placenta, blood and brain MRI we have
shown that IL-8 dysregulation may link systemic inflammation during
perinatal life with altered white matter development in preterm infants.
We found that umbilical cord blood IL-8 concentration was strongly
predictive of histologic chorioamnionitis, which is an intrauterine in-
flammatory condition and leading cause of preterm birth, and that
elevated IL-8 in the first week of postnatal life is associated with white
matter dysmaturation at term-equivalent age.
IL-8 is a member of the CXC chemokine family and a mediator of the
systemic inflammatory response, where its key role is neutrophil che-
motaxis. IL-8 can be secreted by innate and adaptive immune cells and
a variety of CNS cells including astrocytes and microglia (Choi et al.,
2014; Rustenhoven et al., 2016). IL-8 binds to target cells via the G-
protein coupled receptors CXCR1 and CXCR2. These receptors are ex-
pressed throughout the CNS and are associated with key
Table 2
Concentrations of analytes measured from dried blood spots taken from umbilical cord blood of preterm infants with and without exposure to histologic chor-
ioamnionitis.
No HCA (n = 31) HCA (n = 24)
Analyte (pg/ml) Median Q1-Q3 Median Q1-Q3 p value
BDNF 21.4 4.1–30.8 29.3 6.2–48.2 0.072
C3 2451737.0 1655563.9–3373401.2 3859628.4 2265098.7–6336222.3 0.03
C5a 2779.7 1943.1–4172.1 6202.1 3611.9–16932.6 <0.001
C9 583.0 153.7–1483.2 4857.0 1285.0–38747.0 <0.001
CRP 89.0 89.0–195.0 8829.8 89.0–100702.7 0.001
IL-1β 0.0 0.0–0.0 0.5 0.0–0.9 <0.001
IL-6 0.5 0.5–0.5 5.201 0.6–23.2 <0.001
IL-8 7.5 3.4–12.1 106.7 25.5–496.4 <0.001
IL-18 28.1 15.4–47.9 14.5 8.4–35.8 0.06
MCP-1 85.4 65.1–117.2 206.8 104.1–364.5 <0.001
MIP-1β 8.9 4.3–16.8 16.1 11.1–29.9 0.04
MMP-9 11681.7 2139.0–20169.1 16664.4 5242.5–70313.8 0.127
RANTES 1311.4 617.6–2754.4 1540.7 715.6–3349.5 0.519























Fig. 2. ROC curve analysis of cord blood inflammatory markers for the prediction of histologic chorioamnionitis.
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neurodevelopmental processes including cell migration, proliferation
and differentiation, oligodendrocyte maturation, axonal growth and
synaptic plasticity (Deverman and Patterson, 2009; Semple et al., 2010;
Ubogu et al., 2006; Watson et al., 2020). This suggests multiple po-
tential mechanisms through which IL-8 dysregulation during a critical
window of neurodevelopment may disrupt healthy CNS development.
IL-8 dysregulation has been implicated in the pathology of several
types of human brain injury across the life course. It is associated with
blood brain barrier dysfunction in adult traumatic brain injury
(Kossmann et al., 1997; Obermeier et al., 2013), with altered cerebral
metabolism and poor neurodevelopmental outcome following neonatal
hypoxic ischemic injury (Bartha et al., 2004; Foster-Barber et al., 2001)
and with increased mortality in children following traumatic brain in-
jury (Woodcock and Morganti-Kossmann, 2013). Studies focused on the
perinatal period report that elevated IL-8 in blood sampled from the
umbilical cord or soon after birth is associated with overt white matter
injury and cerebral palsy, neurodevelopmental impairment, and cog-
nitive impairment in children born preterm, and it is one of the neo-
natal cytokines that is most strongly associated with subsequent diag-
nosis of autism among children born at term (Carlo et al., 2011;
Hansen-Pupp et al., 2008; Heuer et al., 2019; Kinjo et al., 2011; Kuban
et al., 2017, 2014; Leviton et al., 2019; Silveira and Procianoy, 2011).
Furthermore, studies investigating the maternal immune activation
hypothesis and offspring mental health report that elevated maternal
IL-8 during pregnancy is associated with alterations in brain structure
and an increased risk of schizophrenia in offspring (Brown et al., 2004;
Ellman et al., 2010). This accumulating evidence suggests that in-
flammation associated with elevated IL-8 has a significant adverse
impact on the developing brain with pervasive effects on both structure
and function.
To our knowledge, this is the first study to integrate information
about systemic inflammation from placenta and blood with biomarkers
of white matter microstructure in a representative group of preterm
infants without major parenchymal brain injury. We selected a large
number of inflammation-associated proteins that are important in the
innate and adaptive immune response in the newborn, and used a data
driven approach based on PCA to characterize the inflammatory profile
associated with HCA and white matter microstructure. Our choice of
image features was principled, based on established characterizations
of white matter dysmaturation in preterm infants, namely water con-
tent and dendritic/axonal complexity and dysmaturation within the
white matter skeleton (Blesa et al., 2020; Kunz et al., 2014; Lynch et al.,
2020).
A limitation of the study is that the cytokine response is governed
not only by environmental insults but also by genetic factors and ma-
ternal inflammatory status (Dammann and O'Shea, 2008; Holst and
Garnier, 2008; Sheikh et al., 2016). The sample size was not sufficient
to perform sub-group analyses based on gestational age or examine
potential risks or resilience conferred by the genome, and we did not
have data to permit analysis of maternal cytokines. Instead, we char-
acterized antenatal inflammation using placental tissue, which is most
closely associated with fetal inflammatory responses (Gotsch et al.,
2007). We chose to use a global measure of white matter microstructure
because microstructural properties are substantially shared across the
major white matter tracts of the newborn brain (Telford et al., 2017),
and we hypothesised that systemic inflammation would likely exert a
global effect; different methods would be required to investigate hy-
potheses about tract specific or regional susceptibilities to immune
dysregulation.
5. Conclusions
This study provides further support for a substantial role of gen-
eralized inflammation in the etiology of preterm brain injury, and it
suggests that IL-8 dysregulation may provide a link between systemic
inflammation and brain dysmaturation. Further work to assess causa-
tion is warranted, such as elucidating cell-specific effects of IL-8 on
developing neurons and glia in model systems. Given the potential role
of immunomodulatory therapies for treating diseases of the central
nervous system (Çakici et al., 2019; Wittenberg et al., 2020), and the
availability of anti-IL-8 monoclonal antibody therapies, this finding has
implications for the development of perinatal neuroprotection strate-
gies based on anti-inflammatory and novel immune therapeutics.
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